netFormulary
 Report : A-Z HCD items in Formulary 21/12/2024 16:40:30
[Back]
 
Section Status BlueTeq Name
08.03.04.01 Formulary BlueTeq Abemaciclib Verzenios®
08.01.05 Formulary BlueTeq Acalabrutinib Calquence®
08.01.05 Formulary BlueTeq Alectinib Alecensa®
08.03.04.01 Formulary BlueTeq Alpelisib Piqray®
08.03.04.02 Formulary BlueTeq Apalutamide  Erleada®
08.01.05 Formulary BlueTeq Asciminib Scemblix®
08.01.05 Formulary BlueTeq Atezolizumab 
03.04.02 Formulary BlueTeq Benralizumab Fasenra®
08.01.05 Formulary BlueTeq Brigatinib Alunbrig®
05.03.03.02 Formulary BlueTeq Bulevirtide Hepcludex®
08.01.05 Formulary BlueTeq Carfilzomib Kyprolis®
08.01.05 Formulary BlueTeq Cemiplimab Libtayo®
08.01.05 Formulary BlueTeq Dabrafenib  Tafinlar®
08.01.05 Formulary BlueTeq Dacomitinib Vizimpro®
08.01.05 Formulary BlueTeq Daratumumab Darzalex®
08.03.04.02 Formulary BlueTeq Darolutamide Nubeqa®
08.01.05 Formulary BlueTeq Dinutuximab beta Qarziba®
08.02.04 Formulary BlueTeq Diroximel fumarate Vumerity®
03.04.02 Formulary BlueTeq Dupilumab Dupixent®
08.01.05 Formulary BlueTeq Entrectinib Rozlytrek®
08.01.05 Formulary BlueTeq Epcoritamab Tepkinly®
05.03.01 Formulary BlueTeq Fostemsavir Rukobia®
08.01.05 Formulary BlueTeq Gemtuzumab ozogamicin Mylotarg®
08.01.05 Formulary BlueTeq Gilteritinib Xospata®
08.01.05 Formulary BlueTeq Idelalisib  
08.01.05 Formulary BlueTeq Inotuzumab ozogamicin Besponsa®
08.01.05 Formulary BlueTeq Ipilimumab Yervoy®
08.01.05 Formulary BlueTeq Ivosidenib Tibsovo®
08.01.05 Formulary BlueTeq Loncastuximab tesirine Zynlonta®
08.01.05 Formulary BlueTeq Lorlatinib Lorviqua®
03.04.02 Formulary BlueTeq Mepolizumab Nucala®
10.02 Formulary BlueTeq Mexiletine Namuscla®
08.01.05 Formulary BlueTeq Midostaurin Rydapt®
08.01.05 Formulary BlueTeq Mogamulizumab  Poteligeo®
08.01.05 Formulary BlueTeq Momelotinib Omjjara®
08.01.05 Formulary BlueTeq Neratinib Nerlynx®
08.01.05 Formulary BlueTeq Niraparib Zejula®
08.01.05 Formulary BlueTeq Nivolumab  Opdivo®
08.01.05 Formulary BlueTeq Nivolumab-relatlimab Opdualag®
08.02.03 Formulary BlueTeq Ocrelizumab Ocrevus®
08.02.03 Formulary BlueTeq Ofatumumab  Kesimpta®
08.01.05 Formulary BlueTeq Olaparib  Lynparza®
03.04.02 Formulary BlueTeq Omalizumab Xolair®
08.01.05 Formulary BlueTeq Panobinostat  
08.01.05 Formulary BlueTeq Pembrolizumab  Keytruda®
08.01.05 Formulary BlueTeq Pertuzumab Perjeta®
08.01.05 Formulary BlueTeq Polatuzumab vedotin Polivy®
08.02.04 Formulary BlueTeq Ponesimod Ponvory®
08.01.05 Formulary BlueTeq Regorafenib Stivarga®
03.04.02 Formulary BlueTeq Reslizumab Cinquil®
09.08.01 Formulary BlueTeq Sebelipase alfa Kanuma®
08.01.05 Formulary BlueTeq Selinexor Nexpovio®
08.01.05 Formulary BlueTeq Selumetinib Koselugo®
08.02.04 Formulary BlueTeq Siponimod Mayzent®
03.04.02 Formulary BlueTeq Tezepelumab Tezspire®
10.01.03 Formulary BlueTeq Tocilizumab RoActemra®
09.08.01 Formulary BlueTeq Velmanase alfa Lamzede ®
08.01.05 Formulary BlueTeq Venetoclax Venclyxto®
North East and North Cumbria